Navigation Links
Elekta Negotiates To Acquire CMS
Date:1/8/2008

Acquisition of leading treatment planning software developer would strengthen Elekta's offering and accelerate the company's expansion into

high growth oncology informatics

STOCKHOLM, Sweden, Jan. 8 /PRNewswire/ -- Elekta AB (publ) (STO: EKTAb) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it is in exclusive negotiations based on a Letter of Intent to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. CMS is a worldwide leader in the development, sales and support of advanced radiation therapy planning solutions, supporting over 1,500 sites in clinical operation throughout the world. The transaction is subject to successful conclusion of final transaction documentation, satisfactory completion of due diligence, receipt of relevant regulatory approvals and other conditions. The negotiations are expected to be finalized by mid February 2008 and closing is estimated to take place by mid March 2008.

CMS has been a pioneer in the development and delivery of radiation treatment planning (RTP) systems for over 25 years and continues to be a leader in treatment planning and oncology workflow management. Successful completion of the acquisition process would benefit Elekta by adding a suite of advanced RTP systems, a large and growing installed base, and a well- established RTP operational infrastructure to Elekta's current oncology business. CMS's worldwide sales and support infrastructure and large, experienced engineering organization have the potential to accelerate Elekta's ability to develop, implement, and support new, sophisticated radiation planning, delivery, and management solutions worldwide.

CMS is also the market leader in treatment planning for proton therapy with 8 installations in clinical use. Integrating these solutions with the MOSAIQ(TM) information management system would reinforce Elekta's leadership in s
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
2. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
3. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
4. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
5. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
9. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
10. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
11. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... This June 13th, a distinguished group ... and International Medical Schools will come together in Santa ... application of stem cell therapy in treatments and cures ... funded by the Ocular Research Symposia Foundation, Inc. ... intimate meetings of top experts in the field of ...
(Date:3/31/2015)... Cleveland, OH (PRWEB) March 31, 2015 ... from its licensor, SDG, Inc., that a United States ... for liver-targeted insulin therapy. , Entitled “Lipid ... patent covers composition of matter claims related to the ... a system for enabling injected insulin to more effectively ...
(Date:3/30/2015)... Francisco, CA (PRWEB) March 30, 2015 ... tax incentives provided you the government, major companies are ... and local governments setting future mandates for renewable energy ... as an option. , Solara Power is a new ... several incentive programs available that allow qualifying homeowners to ...
(Date:3/30/2015)...  Multiple new research abstracts suggest walnuts may have ... From their impact on colon cancer and certain aspects ... gut health and vascular health, the research findings presented ... of walnuts, inner workings. Running March 28 through April ... meeting attracts an international audience of over 14,000 leading ...
Breaking Biology Technology:Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4
... Readies R & D facilities for Ap3ana, CTI,s ... Cell Therapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ... President and COO of a Tyr Pharma and ... the Novartis Research,Foundation, has been named President of ...
... BioPharma,Corp. (TSX; FSE: HBP) today announced that it has ... 6,800,000 units at $1.68 per,unit, for gross proceeds totaling ... and one-half of one common share,purchase warrant, with each ... subject to adjustment, one common share at a price,of ...
... Investors, WILMINGTON, Del., Oct. 2 Speaking ... General Manager John Ranieri,said the company,s plans to ... on track and making significant technical progress toward ... feedstocks,economically into biofuels., "Biobutanol and cellulosic ethanol ...
Cached Biology Technology:Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
(Date:3/2/2015)... SAN JOSE, Calif. , March 2, 2015 ... ), the leading developer of human interface solutions, ... ID technology that is designed to enable rapid ... Synaptics Natural ID™ module for gaming is a ... and ODMs the ability to quickly integrate fingerprint ...
(Date:3/2/2015)... Lithuania , March 2, 2015   Neurotechnology ... technologies, today introduced the SentiGaze Software Development Kit ... to create applications that use off-the-shelf webcams to track ... user gazes at a monitor. Heatmaps can be used ... the effectiveness of online advertising. The SDK can also ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... obesity increasing, school administrators and public health officials are ... a study published in the November/December 2008 issue of ... researchers found that reduction or elimination of SSB from ... adolescents. Working with four schools in Maine ...
... to be averted, atmospheric carbon dioxide (CO2) must be reduced below ... in Open Atmospheric Science Journal by a ... and France. The authors, who include two Yale ... which civilization developed, an optimum CO2 level would be less than ...
... Ph.D., of the New York City Department of Health and ... be one of our body,s main protections against damage from ... of Low Radiation , Hayes explains that calcitriol, the active ... and could be used as a safe protective agent before ...
Cached Biology News:Revised theory suggests carbon dioxide levels already in danger zone 2Could vitamin D save us from radiation? 2
... monoclonal [198C679.2.1] to Presenilin 2 Alzheimer's ... of the disease carry mutations in the ... precursor protein (APP). These disease-linked mutations result ... of amyloid-beta (main component of amyloid deposits ...
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
... This volume provides excellent background information, ... study of major HIV proteins including: the ... integrase and protease. Expression of HIV proteins ... Rev assays; HIV/CD4 interactions; transient assays for ...
Human Contactin-2/TAG1 Affinity Purified Polyclonal Ab...
Biology Products: